CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Due to Related Parties, Current
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Due to Related Parties, Current of -$61.76 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2024-03-11
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-12-31 was $7.30K, a 43.80% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-09-30 was $1.55K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-06-30 was -$89.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-03-31 was -$70.52K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2023 was -$61.76K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2022 was -$510.15K, a 186.41% decline from fiscal 2021.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2021 was $590.42K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in due to related parties, current for fiscal 2012 was -$22.75K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month | Increase (Decrease) in Due to Related Parties, Current 71 month | Increase (Decrease) in Due to Related Parties, Current 74 month | Increase (Decrease) in Due to Related Parties, Current 77 month | Increase (Decrease) in Due to Related Parties, Current 80 month | Increase (Decrease) in Due to Related Parties, Current 83 month | Increase (Decrease) in Due to Related Parties, Current 86 month | Increase (Decrease) in Due to Related Parties, Current 89 month | Increase (Decrease) in Due to Related Parties, Current 92 month | Increase (Decrease) in Due to Related Parties, Current 95 month | Increase (Decrease) in Due to Related Parties, Current 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $7.30K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $8.85K derived: sum of 2 quarters · filed 2024-03-11 | $8.76K derived: sum of 3 quarters · filed 2024-03-11 | -$61.76K 10-K · filed 2024-03-11 | ||||||||||
| 2023-09-30 | $1.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.46K derived: sum of 2 quarters · filed 2023-11-14 | -$69.06K 10-Q · filed 2023-11-14 | -$63.98K derived: sum of 4 quarters · filed 2024-03-11 | ||||||||||
| 2023-06-30 | -$89.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$70.61K 10-Q · filed 2023-08-08 | -$65.53K derived: sum of 3 quarters · filed 2024-03-11 | -$75.51K derived: sum of 4 quarters · filed 2024-03-11 | ||||||||||
| 2023-03-31 | -$70.52K 10-Q · filed 2023-05-12 | -$65.44K derived: sum of 2 quarters · filed 2024-03-11 | -$75.42K derived: sum of 3 quarters · filed 2024-03-11 | -$556.13K derived: sum of 4 quarters · filed 2024-03-11 | ||||||||||
| 2022-12-31 | $5.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$4.90K derived: sum of 2 quarters · filed 2024-03-11 | -$485.61K derived: sum of 3 quarters · filed 2024-03-11 | -$510.15K 10-K · filed 2024-03-11 | ||||||||||
| 2022-09-30 | -$9.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$490.69K derived: sum of 2 quarters · filed 2023-11-14 | -$515.23K 10-Q · filed 2023-11-14 | -$412.92K derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||
| 2022-06-30 | -$480.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$505.25K 10-Q · filed 2023-08-08 | -$402.94K derived: sum of 3 quarters · filed 2023-08-08 | -$281.52K derived: sum of 4 quarters · filed 2023-08-08 | ||||||||||
| 2022-03-31 | -$24.54K 10-Q · filed 2023-05-12 | $77.77K derived: sum of 2 quarters · filed 2023-05-12 | $199.20K derived: sum of 3 quarters · filed 2023-05-12 | $253.51K derived: sum of 4 quarters · filed 2023-05-12 | ||||||||||
| 2021-12-31 | $102.31K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $223.74K derived: sum of 2 quarters · filed 2023-03-17 | $278.05K derived: sum of 3 quarters · filed 2023-03-17 | $590.42K 10-K · filed 2023-03-17 | ||||||||||
| 2021-09-30 | $121.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $175.75K derived: sum of 2 quarters · filed 2022-11-10 | $488.11K 10-Q · filed 2022-11-10 | |||||||||||
| 2021-06-30 | $54.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $366.68K 10-Q · filed 2022-08-12 | ||||||||||||
| 2021-03-31 | $312.36K 10-Q · filed 2022-05-11 | |||||||||||||
| 2013-09-30 | $4.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $11.40K derived: sum of 2 quarters · filed 2013-11-14 | $1.86K 10-Q · filed 2013-11-14 | $9.93K derived: sum of 4 quarters · filed 2013-11-14 | $18.00K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $6.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.94K 10-Q · filed 2013-08-14 | $5.13K derived: sum of 3 quarters · filed 2013-08-14 | -$23.25K derived: sum of 4 quarters · filed 2013-11-14 | $13.20K 10-Q · filed 2013-08-14 | |||||||||
| 2013-03-31 | -$9.54K 10-Q · filed 2013-06-21 | -$1.47K derived: sum of 2 quarters · filed 2013-06-21 | -$29.85K derived: sum of 3 quarters · filed 2013-11-14 | -$91.69K derived: sum of 4 quarters · filed 2013-11-14 | $6.60K 10-Q · filed 2013-06-21 | |||||||||
| 2012-12-31 | $8.07K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | -$20.31K derived: sum of 2 quarters · filed 2013-11-14 | -$82.15K derived: sum of 3 quarters · filed 2013-11-14 | -$22.75K 10-K · filed 2013-06-21 | $16.14K 10-K · filed 2013-06-21 | |||||||||
| 2012-09-30 | -$28.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$90.22K derived: sum of 2 quarters · filed 2013-11-14 | -$30.83K 10-Q · filed 2013-11-14 | -$28.10K derived: sum of 4 quarters · filed 2013-11-14 | $8.07K 10-Q · filed 2013-06-21 | |||||||||
| 2012-06-30 | -$61.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.44K 10-Q · filed 2013-08-14 | $281.00 derived: sum of 3 quarters · filed 2013-08-14 | -$923.00 derived: sum of 4 quarters · filed 2013-08-14 | $36.45K 10-Q/A · filed 2012-09-10 | |||||||||
| 2012-03-31 | $59.40K 10-Q · filed 2013-06-21 | $62.12K derived: sum of 2 quarters · filed 2013-06-21 | $60.92K derived: sum of 3 quarters · filed 2013-06-21 | $14.69K derived: sum of 4 quarters · filed 2013-06-21 | $98.29K 10-Q · filed 2012-05-15 | |||||||||
| 2011-12-31 | $2.73K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $1.52K derived: sum of 2 quarters · filed 2013-06-21 | -$44.71K derived: sum of 3 quarters · filed 2013-06-21 | -$45.54K 10-K · filed 2013-06-21 | $38.89K 10-K · filed 2012-04-02 | |||||||||
| 2011-09-30 | -$1.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | -$47.44K derived: sum of 2 quarters · filed 2013-06-21 | -$48.26K 10-Q · filed 2013-06-21 | -$39.07K derived: sum of 4 quarters · filed 2013-06-21 | $36.17K 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | -$46.23K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | -$47.06K 10-Q/A · filed 2012-09-10 | -$37.87K derived: sum of 3 quarters · filed 2012-09-10 | -$41.53K derived: sum of 4 quarters · filed 2012-09-10 | $37.37K 10-Q · filed 2011-08-15 | |||||||||
| 2011-03-31 | -$828.00 10-Q · filed 2012-05-15 | $8.36K derived: sum of 2 quarters · filed 2012-05-15 | $4.70K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||
| 2010-12-31 | $9.19K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $5.53K derived: sum of 2 quarters · filed 2012-04-02 | $276.00 10-K · filed 2012-04-02 | |||||||||||
| 2010-09-30 | -$3.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$8.92K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | -$5.25K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |